1 Kolchina AN, Yatsyshina EE, Malysheva LV, et al. Diagnostics of inherited metabolic diseases in newborns with the hyperammonemia syndrome at the onset of disease (pilot study)[J]. Sovrem Tekhnologii Med, 2021, 13(1): 59-64. PMID: 34513067. PMCID: PMC8353695. DOI: 10.17691/stm2021.13.1.07.
2 Ribas GS, Lopes FF, Deon M, et al. Hyperammonemia in inherited metabolic diseases[J]. Cell Mol Neurobiol, 2022, 42(8): 2593-2610. PMID: 34665389. DOI: 10.1007/s10571-021-01156-6.
3 Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations[J]. BMJ, 2008, 336(7650): 924-926. PMID: 18436948. PMCID: PMC2335261. DOI: 10.1136/bmj.39489.470347.AD.
4 Raina R, Bedoyan JK, Lichter-Konecki U, et al. Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy[J]. Nat Rev Nephrol, 2020, 16(8): 471-482. PMID: 32269302. PMCID: PMC7366888. DOI: 10.1038/s41581-020-0267-8.
5 Alfadhel M, Mutairi FA, Makhseed N, et al. Guidelines for acute management of hyperammonemia in the Middle East region[J]. Ther Clin Risk Manag, 2016, 12: 479-487.
6 Auron A, Brophy PD. Hyperammonemia in review: pathophysiology, diagnosis, and treatment[J]. Pediatr Nephrol, 2012, 27(2): 207-222. PMID: 21431427. DOI: 10.1007/s00467-011-1838-5.
7 Colombo JP, Peheim E, Kretschmer R, et al. Plasma ammonia concentrations in newborns and children[J]. Clin Chim Acta, 1984, 138(3): 283-291. PMID: 6723064. DOI: 10.1016/0009-8981(84)90135-9.
8 H?berle J. Clinical and biochemical aspects of primary and secondary hyperammonemic disorders[J]. Arch Biochem Biophys, 2013, 536(2): 101-108. PMID: 23628343. DOI: 10.1016/j.abb.2013.04.009.
9 H?berle J. Clinical practice: the management of hyperammonemia[J]. Eur J Pediatr, 2011, 170(1): 21-34. PMID: 21165747. DOI: 10.1007/s00431-010-1369-2.
10 Warrillow S, Fisher C, Bellomo R. Correction and control of hyperammonemia in acute liver failure: the impact of continuous renal replacement timing, intensity, and duration[J]. Crit Care Med, 2020, 48(2): 218-224. PMID: 31939790. DOI: 10.1097/CCM.0000000000004153.
11 Bergmann KR, McCabe J, Smith TR, et al. Late-onset ornithine transcarbamylase deficiency: treatment and outcome of hyperammonemic crisis[J]. Pediatrics, 2014, 133(4): e1072-e1076. PMID: 24616362. DOI: 10.1542/peds.2013-1324.
12 Lee B, Diaz GA, Rhead W, et al. Blood ammonia and glutamine as predictors of hyperammonemic crises in patients with urea cycle disorder[J]. Genet Med, 2015, 17(7): 561-568. PMID: 25503497. PMCID: PMC4465427. DOI: 10.1038/gim.2014.148.
13 Nakamura K, Kido J, Mitsubuchi H, et al. Diagnosis and treatment of urea cycle disorder in Japan[J]. Pediatr Int, 2014, 56(4): 506-509. PMID: 25039902. DOI: 10.1111/ped.12439.
14 Bigot A, Tchan MC, Thoreau B, et al. Liver involvement in urea cycle disorders: a review of the literature[J]. J Inherit Metab Dis, 2017, 40(6): 757-769. PMID: 28900784. DOI: 10.1007/s10545-017-0088-5.
15 Ogier de Baulny H, Schiff M, Dionisi-Vici C. Lysinuric protein intolerance (LPI): a multi organ disease by far more complex than a classic urea cycle disorder[J]. Mol Genet Metab, 2012, 106(1): 12-17. PMID: 22402328. DOI: 10.1016/j.ymgme.2012.02.010.
16 Ro?enková K, Güemes M, Shah P, et al. The diagnosis and management of hyperinsulinaemic hypoglycaemia[J]. J Clin Res Pediatr Endocrinol, 2015, 7(2): 86-97. PMID: 26316429. PMCID: PMC4563192. DOI: 10.4274/jcrpe.1891.
17 Martinelli D, H?berle J, Rubio V, et al. Understanding pyrroline-5-carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine[J]. J Inherit Metab Dis, 2012, 35(5): 761-776. PMID: 22170564. DOI: 10.1007/s10545-011-9411-8.
18 Ballard RA, Vinocur B, Reynolds JW, et al. Transient hyperammonemia of the preterm infant[J]. N Engl J Med, 1978, 299(17): 920-925. PMID: 692597. DOI: 10.1056/NEJM197810262991704.
19 王恋, 李娟, 毛健, 等. 极低及超低出生体重儿的预后因素分析[J]. 中国当代儿科杂志, 2014, 16(6): 601-605. PMID: 24927435. DOI: 10.7499/j.issn.1008-8830.2014.06.008.
20 Vergano SA, Crossette JM, Cusick FC, et al. Improving surveillance for hyperammonemia in the newborn[J]. Mol Genet Metab, 2013, 110(1-2): 102-105. PMID: 23746553. PMCID: PMC3755016. DOI: 10.1016/j.ymgme.2013.05.005.
21 Van Geet C, Vandenbossche L, Eggermont E, et al. Possible platelet contribution to pathogenesis of transient neonatal hyperammonaemia syndrome[J]. Lancet, 1991, 337(8733): 73-75. PMID: 1670726. DOI: 10.1016/0140-6736(91)90736-9.
22 Tuchman M, Georgieff MK. Transient hyperammonemia of the newborn: a vascular complication of prematurity?[J]. J Perinatol, 1992, 12(3): 234-236. PMID: 1432279.
23 Ames EG, Powell C, Engen RM, et al. Multisite retrospective review of outcomes in renal replacement therapy for neonates with inborn errors of metabolism[J]. J Pediatr, 2022, 246: 116-122.e1. PMID: 35358588. PMCID: PMC9233075. DOI: 10.1016/j.jpeds.2022.03.043.
24 Westrope C, Morris K, Burford D, et al. Continuous hemofiltration in the control of neonatal hyperammonemia: a 10-year experience[J]. Pediatr Nephrol, 2010, 25(9): 1725-1730. PMID: 20495829. DOI: 10.1007/s00467-010-1549-3.
25 曾健生. 高氨血症相关遗传代谢病危重症[J]. 中国实用儿科杂志, 2015, 30(8): 573-578. DOI: 10.7504/ek2015080604.
26 金润铭, 杨爱德. 小儿高氨血症的诊断和治疗[J]. 中国实用儿科杂志, 2000, 15(2): 75-77. DOI: 10.3969/j.issn.1005-2224.2000.02.005.
27 陆妹. 尿素循环障碍导致的危重症识别及对策[J]. 中国实用儿科杂志, 2021, 36(10): 735-738. DOI: 10.19538/j.ek2021100604.
28 中国医师协会医学遗传医师分会临床生化专业委员会, 中华医学会儿科学分会内分泌遗传代谢学组, 中国妇幼保健协会儿童疾病和保健分会遗传代谢学组, 等. 中国尿素循环障碍诊断治疗和管理指南[J]. 中华儿科杂志, 2022, 60(11): 1118-1126. PMID: 36319144. DOI: 10.3760/cma.j.cn112140-20220412-00319.
29 Paprocka J, Jamroz E. Hyperammonemia in children: on the crossroad of different disorders[J]. Neurologist, 2012, 18(5): 261-265. PMID: 22931730. DOI: 10.1097/NRL.0b013e318266f58a.
30 Matoori S, Leroux JC. Recent advances in the treatment of hyperammonemia[J]. Adv Drug Deliv Rev, 2015, 90: 55-68. PMID: 25895618. DOI: 10.1016/j.addr.2015.04.009.
31 Bachmann C. Mechanisms of hyperammonemia[J]. Clin Chem Lab Med, 2002, 40(7): 653-662. PMID: 12241009. DOI: 10.1515/CCLM.2002.112.
32 Dasarathy S, Mookerjee RP, Rackayova V, et al. Ammonia toxicity: from head to toe?[J]. Metab Brain Dis, 2017, 32(2): 529-538. PMID: 28012068. PMCID: PMC8839071. DOI: 10.1007/s11011-016-9938-3.
33 Broomfield A, Grunewald S. How to use serum ammonia[J]. Arch Dis Child Educ Pract Ed, 2012, 97(2): 72-77; answer to quiz pg 80. PMID: 22101094. DOI: 10.1136/archdischild-2011-300194.
34 Hansen L, Lind-Thomsen A, Joshi HJ, et al. A glycogene mutation map for discovery of diseases of glycosylation[J]. Glycobiology, 2015, 25(2): 211-224. PMID: 25267602. PMCID: PMC4351397. DOI: 10.1093/glycob/cwu104.
35 Tarailo-Graovac M, Shyr C, Ross CJ, et al. Exome sequencing and the management of neurometabolic disorders[J]. N Engl J Med, 2016, 374(23): 2246-2255. PMID: 27276562. PMCID: PMC4983272. DOI: 10.1056/NEJMoa1515792.
36 Taylor RW, Pyle A, Griffin H, et al. Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies[J]. JAMA, 2014, 312(1): 68-77. PMID: 25058219. PMCID: PMC6558267. DOI: 10.1001/jama.2014.7184.
37 H?berle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision[J]. J Inherit Metab Dis, 2019, 42(6): 1192-1230. PMID: 30982989. DOI: 10.1002/jimd.12100.
38 Burton BK. Inborn errors of metabolism in infancy: a guide to diagnosis[J]. Pediatrics, 1998, 102(6): E69. PMID: 9832597. DOI: 10.1542/peds.102.6.e69.
39 Leonard JV, Morris AA. Diagnosis and early management of inborn errors of metabolism presenting around the time of birth[J]. Acta Paediatr, 2006, 95(1): 6-14. PMID: 16373289. DOI: 10.1080/08035250500349413.
40 Batshaw ML, Wachtel RC, Cohen L, et al. Neurologic outcome in premature infants with transient asymptomatic hyperammonemia[J]. J Pediatr, 1986, 108(2): 271-275. PMID: 3511207. DOI: 10.1016/s0022-3476(86)81003-4.
41 Enns GM, Berry SA, Berry GT, et al. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders[J]. N Engl J Med, 2007, 356(22): 2282-2292. PMID: 17538087. DOI: 10.1056/NEJMoa066596.
42 Chakrapani A, Cleary MA, Wraith JE. Detection of inborn errors of metabolism in the newborn[J]. Arch Dis Child Fetal Neonatal Ed, 2001, 84(3): F205-F210. PMID: 11320051. PMCID: PMC1721249. DOI: 10.1136/fn.84.3.f205.
43 Wang HS, Kuo MF, Chou ML, et al. Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy[J]. Arch Dis Child, 2005, 90(5): 512-515. PMID: 15851435. PMCID: PMC1720393. DOI: 10.1136/adc.2003.045963.
44 Nasser M, Javaheri H, Fedorowicz Z, et al. Carnitine supplementation for inborn errors of metabolism[J]. Cochrane Database Syst Rev, 2012, 2012(2): CD006659. PMID: 22336821. PMCID: PMC7390060. DOI: 10.1002/14651858.CD006659.pub3.
45 Batshaw ML, Brusilow S, Waber L, et al. Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion[J]. N Engl J Med, 1982, 306(23): 1387-1392. PMID: 7078580. DOI: 10.1056/NEJM198206103062303.
46 Matoori S, Forster V, Agostoni V, et al. Preclinical evaluation of liposome-supported peritoneal dialysis for the treatment of hyperammonemic crises[J]. J Control Release, 2020, 328: 503-513. PMID: 32860926. DOI: 10.1016/j.jconrel.2020.08.040.
47 Chen YJ, Hung HH, Li CY, et al. A central venous catheter as an alternative peritoneal dialysis tube in an extremely low birth weight infant: a practical life-saving method for medical-resource-limited institutions[J]. J Formos Med Assoc, 2021, 120(10): 1928-1929. PMID: 34247892. DOI: 10.1016/j.jfma.2021.06.021.
48 Le Page AK, Stewart AE, Roehr CC, et al. The use of peritoneal dialysis in phenobarbitone toxicity in a critically unwell neonate[J]. Neonatology, 2018, 113(2): 117-121. PMID: 29169160. DOI: 10.1159/000481879.
49 Wu X, Vega M, Swartz SJ, et al. Milky appearance of peritoneal fluid in a neonate on peritoneal dialysis due to end-stage renal disease: answers[J]. Pediatr Nephrol, 2018, 33(1): 73-76. PMID: 28283762. DOI: 10.1007/s00467-017-3633-4.
50 Celik M, Akdeniz O, Ozgun N. Efficacy of peritoneal dialysis in neonates presenting with hyperammonaemia due to urea cycle defects and organic acidaemia[J]. Nephrology (Carlton), 2019, 24(3): 330-335. PMID: 29356227. DOI: 10.1111/nep.13224.
51 中华医学会儿科学分会新生儿学组. 连续性血液净化治疗新生儿急性肾损伤专家共识[J]. 中华儿科杂志, 2021, 59(4): 264-269. PMID: 33775043. DOI: 10.3760/cma.j.cn112140-20200922-00898.
52 Bellomo R, Baldwin I, Ronco C, et al. ICU-based renal replacement therapy[J]. Crit Care Med, 2021, 49(3): 406-418. PMID: 33555775. DOI: 10.1097/CCM.0000000000004831.
53 See EJ, Bellomo R. How I prescribe continuous renal replacement therapy[J]. Crit Care, 2021, 25(1): 1. PMID: 33388077. PMCID: PMC7777364. DOI: 10.1186/s13054-020-03448-7.
54 周文浩, 陆国平. 连续性血液净化治疗新生儿急性肾损伤专家共识解读[J]. 中华儿科杂志, 2021, 59(4): 270-272. PMID: 33775044. DOI: 10.3760/cma.j.cn112140-20210126-00071.
55 Eisenstein I, Pollack S, Hadash A, et al. Acute hemodialysis therapy in neonates with inborn errors of metabolism[J]. Pediatr Nephrol, 2022, 37(11): 2725-2732. PMID: 35239033. DOI: 10.1007/s00467-022-05507-3.
56 Spinale JM, Laskin BL, Sondheimer N, et al. High-dose continuous renal replacement therapy for neonatal hyperammonemia[J]. Pediatr Nephrol, 2013, 28(6): 983-986. PMID: 23471476. PMCID: PMC3633740. DOI: 10.1007/s00467-013-2441-8.
57 Chan WK, But WM, Law CW. Ammonia detoxification by continuous venovenous haemofiltration in an infant with urea cycle defect[J]. Hong Kong Med J, 2002, 8(3): 207-210. PMID: 12055368.
58 Picca S, Dionisi-Vici C, Bartuli A, et al. Short-term survival of hyperammonemic neonates treated with dialysis[J]. Pediatr Nephrol, 2015, 30(5): 839-847. PMID: 25185886. DOI: 10.1007/s00467-014-2945-x.
59 Lai YC, Huang HP, Tsai IJ, et al. High-volume continuous venovenous hemofiltration as an effective therapy for acute management of inborn errors of metabolism in young children[J]. Blood Purif, 2007, 25(4): 303-308. PMID: 17643056. DOI: 10.1159/000106102.
60 Unsinn C, Das A, Valayannopoulos V, et al. Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013[J]. Orphanet J Rare Dis, 2016, 11(1): 116. PMID: 27538463. PMCID: PMC4991093. DOI: 10.1186/s13023-016-0493-0.
61 Bijarnia-Mahay S, H?berle J, Jalan AB, et al. Urea cycle disorders in India: clinical course, biochemical and genetic investigations, and prenatal testing[J]. Orphanet J Rare Dis, 2018, 13(1): 174. PMID: 30285816. PMCID: PMC6167905. DOI: 10.1186/s13023-018-0908-1.
62 Kido J, Matsumoto S, Ito T, et al. Physical, cognitive, and social status of patients with urea cycle disorders in Japan[J]. Mol Genet Metab Rep, 2021, 27: 100724. PMID: 33614409. PMCID: PMC7876628. DOI: 10.1016/j.ymgmr.2021.100724.
63 Kido J, Matsumoto S, H?berle J, et al. Long-term outcome of urea cycle disorders: report from a nationwide study in Japan[J]. J Inherit Metab Dis, 2021, 44(4): 826-837. PMID: 33840128. DOI: 10.1002/jimd.12384.
64 Kido J, Matsumoto S, H?berle J, et al. Role of liver transplantation in urea cycle disorders: report from a nationwide study in Japan[J]. J Inherit Metab Dis, 2021, 44(6): 1311-1322. PMID: 34232532. DOI: 10.1002/jimd.12415.
65 McBride KL, Miller G, Carter S, et al. Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine transcarbamylase deficiency[J]. Pediatrics, 2004, 114(4): e523-e526. PMID: 15466081. DOI: 10.1542/peds.2004-0198.